Former exec at drugmaker Ipsen sentenced to prison for insider trading
By Nate Raymond BOSTON (Reuters) -A former executive at French drugmaker Ipsen was sentenced on Thursday to two months in a U.S. prison for illegally trading on inside information he learned about his company’s plans to acquire cancer drug developer Epizyme in 2022. Dishant Gupta, Ipsen’s former director of data strategy and operations, was sentenced …
Former exec at drugmaker Ipsen sentenced to prison for insider trading Read More »










